Sponsor

Bukwang Pharmaceutical

Clinical research sponsor

Published trials7

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

7 shown

Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant MonotherapyNCT07781293 · lead sponsor · 2026-09-28

NOT_YET_RECRUITING

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male SubjectsNCT06014853 · lead sponsor · 2023-08-10

COMPLETED

Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual ComponentsNCT04377945 · lead sponsor · 2021-04-28

TERMINATED

A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With SchizophreniaNCT03465787 · lead sponsor · 2018-04-09

COMPLETED

Efficacy and Safety of JM-010 in PD With Levodopa-Induced DyskinesiaNCT02439203 · lead sponsor · 2015-05-01

COMPLETED

Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic NeuropathyNCT01261143 · lead sponsor · 2010-08-01

COMPLETED

A Study in Parkinson's Disease in Patients With Moderate to Severe DyskinesiaNCT03956979 · collaborator · 2019-07-22

COMPLETED

Sponsor roles

lead sponsor6

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.